Just three weeks into President Trump's second term, cracks are already showing in his commitment to the pro-life movement that helped propel him back to the White House. The FDA is reportedly dragging its feet on reviewing the dangerous abortion drug mifepristone, leaving frustrated Trump allies in Congress and pro-life states wondering if they've been betrayed.
This isn't just about politics, folks – this is about women's lives. Mifepristone has been linked to serious complications including hemorrhaging, infection, and even death. Yet the same federal bureaucrats who spent four years under Biden rubber-stamping every progressive agenda item are now suddenly moving at a snail's pace when it comes to protecting women from a demonstrably dangerous drug.
The question Patriots are asking is simple: Is this deliberate sabotage by deep state holdovers in the FDA, or has Trump's team simply not prioritized the pro-life agenda that got them elected?
This slow-walking is particularly galling given how quickly the Trump administration has moved on other priorities. Mass deportations? Check. Energy deregulation? Underway. But when it comes to protecting women from a dangerous abortion drug, suddenly we're told these things take time.
Meanwhile, pro-life states that have spent years fighting to protect women and unborn children are watching the federal government fail to back them up. These states trusted Trump's promises and invested their political capital in supporting his agenda. Now they're left wondering if those promises were just campaign rhetoric.
The pro-life movement didn't fight for decades just to be told "trust the process" by the same FDA that fast-tracked experimental COVID vaccines. American women deserve better than bureaucratic games with their health and safety.
Will President Trump step in and force his FDA to actually protect women, or will pro-life voters learn they've been taken for granted once again?
Award-winning journalist covering breaking news, politics & culture for Next News Network.
Source: Next News Network
